By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Biodesix today announced it is collaborating with biopharma Kadmon to evaluate the use of Biodesix's test for a non-small cell lung cancer study for Kadmon's reversible tyrosine kinase inhibitor.
Registering provides access to this and other free content.
Already have an account?Login Now.
BGI CEO Ye Yin says that mapping variation within the human genome will bring a "big data revolution" to healthcare, Wired UK writes.
All the images that investigators produce through their research present a challenge to share, Nature News reports.
The House of Representatives science committee has approved a measure that includes new rules for large National Science Foundation projects, ScienceInsider reports.
In PLOS this week: founder mutation linked to some leukoencephalopathy cases, transcript and protein profiles of the kissing bug, and more.